Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram and Moclobemide for Betel-Quid Dependence
NCT03010761Phase 2Terminated
- Sponsor
- China Medical University Hospital
- Start
- Jan 2016
- Primary completion
- Jan 2018
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of escitalopram, moclobemide in Betel quid dependence (BQD), sponsored by China Medical University Hospital. Started Jan 2016; status: terminated.
02
Drugs
escitaloprammoclobemide
03
Conditions
Betel quid dependence (BQD)
Beyond the preview
Go deeper on NCT03010761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03010761.